Antivirals: The Future of Disease Combat in India

Speedy Summary:

• The article mentions recent patents related to antiviral compositions and methods for treatment.
• Published in Nature Biotechnology, Vol. 43, Issue August 2025.
• DOI for the study: https://doi.org/10.1038/s41587-025-02760-3.

For access, options include:

1. Nature+ subscription at €27.99 per month (online access).
2. Annual journal subscription-€195.33 annually (12 print issues + online).
3. Purchase of article via SpringerLink.

Subscribers may benefit from additional institutional access plans outlined on the publisher’s website.

Indian Opinion Analysis:

The mention of antiviral patents holds potential relevance for India-a contry with a burgeoning pharmaceutical sector focused on generic drug production and affordable treatments globally. Innovations in antivirals could positively impact India by shaping new avenues of research collaborations or technology transfers, particularly as the nation tackles infectious diseases like Dengue or increasingly newer viruses such as Nipah Virus outbreaks locally that previously lacked swift cures globally neutral bioenefit balance flexibly overall improving finds…

Read more: Nature article Link